Hall A, Wright C, Zimmern R. Regulating direct-to-consumer genetic tests: What is all the fuss about?. Genetics in Medicine. 2010 Oct 1 [Epub ahead of print]

Nacul L, Moorthie S, Kapila M, Zimmern R. Addressing congenital causes of disability. The Lancet. 2010 Jan 30;375(9712):374

Oleary P, Zimmern R. Genomics and public health: translating research into public benefit.. Public Health Genomics. 2010;13(4):193-6

Burton H, Wright C, Zimmern R. A new strategic phase for genomic medicine in UK health services. Genome Medicine. 2009 Oct 12;1(10):93

Zimmern R. Genomic medicine: the future is now. Lessons for Hong Kong from the House of Lords Report on Genomic Medicine. Hong Kong Medical Journal. 2009 Oct;15(5):324-5

Zimmern R. Testing challenges: evaluation of novel diagnostics and molecular biomarkers. Clinical Medicine. 2009 Feb 9(1): 68-73

Melzer D, Hogarth S, Liddell K, Ling T, Sanderson S, Zimmern R. Genetic tests for common diseases: new insights, old concerns. British Medical Journal. 2008 Mar 15;336(7644):590-3

Burke W, Zimmern R, Kroese M. Defining purpose: a key step in genetic test evaluation. Genetics in Medicine. 2007 9(10):675-681

Khoury M, Gwinn M, Burke W, Bowen S, Zimmern R. Will genomics widen or help heal the schism between medicine and public health?. American Journal of Preventive Medicine. 2007 Oct; 33(4):310-17

Kroese M, Zimmern R, Pinder S. HER2 status in breast cancer - an example of pharmacogenetic testing. Journal of the Royal Society of Medicine. 2007 Jul;100(7):326-9

Kroese M, Zimmern R. The evaluation of genetic tests. Journal of Public Health. 2007 May 24; [Epub ahead of print]

Higgins J, Ioannidis J, Little J, Gwinn M, Zimmern R. A roadmap for developing an efficient and credible human genome epidemiology. Nature Genetics. 2006;38(1):3-5

Stewart A, Zimmern R. Public health genomics: origins and basic concepts. Italian Journal of Public Health. 2006; 3, 9-15

Burke W, Khoury M, Stewart A, Zimmern R, Bellagio Group . The path from genome-based research to population health: development of an international public health genomics network. Genetics In Medicine. 2006 Jul;8(7):451-8

Burton H, Zimmern R. Education in the genetics era: genetics education for health professionals - an essential component of genetics policy. Medical Education. 2005;39(3):243-4

Raven A, Melzer D, Ling T, Detmer D, Zimmern R. Pharmacogenetics: policy needs for personal prescribing. Journal of Health Services Research and Policy. 2005;10(1):40-4

Higgins J, Sanderson S, Zimmern R, Kroese M, Patch C, Emery J. How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom. Genetics in Medicine. 2005;7(7):495-500

Zimmern R, Burke W. Ensuring the appropriate use of genetic tests. Nature Reviews Genetics. 2004;5(12):955-8

Kroese M, Zimmern R. Genetic tests and their evaluation: Can we answer the key questions? Genetics in Medicine. 2004;6(6):475-80

Menon D, Liddell K, Zimmern R. The Human Tissue Bill and the Mental Capacity Bill. British Medical Journal. 2004;328(7455):1510-1

Detmer D, Melzer D, Zimmern R, Ling T. Regulatory options for pharmacogenetics. Pharmacogenomics. 2003;4(5):527-30

Melzer D, Detmer D, Zimmern R. Pharmacogenetics and public policy: expert views in Europe and North America. Pharmacogenomics. 2003;4(6):689-91

Stewart A, Zimmern R. (Almost) three cheers for UK genetics White Paper. The Lancet. 2003;362(9381):341-2

Austin M, Zimmern R, Humphries S. High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia. Genetics in Medicine. 2002;4(4):275-8

Melzer D, Zimmern R. Genetics and medicalisation. British Medical Journal. 2002;324(7342):863-4

Pharoah P, Antoniou A, Bobrow M, Zimmern R, Easton D, Ponder B. Polygenic susceptibility to breast cancer and implications for prevention. Nature. 2002;31(1):33-6